Tina-Quant (Latex) HS Test System (C-Reactive Protein (Latex) High Sensitive) The Tina-Quant CRP (Latex) High Sensitive Immunoturbidimetric assay is for the in-vitro quantitative determination of C-reactive protein (CRP) in human serum and plasma on Roche automated clinical chemistry analyzers. High
Check against the official notice below — it lists the full affected range.
Roche Diagnostics Operations, Inc. is recalling Tina-Quant Cardiac C-Reactive Protein (Latex) High Sensitive test kits, specifically lot number 604450 (catalog number 11972855216). The tests show an under-recovery of up to -25% at concentrations below 5 mg/L when used on the MODULAR ANALYTICS P module, meaning results can be incorrectly low. C-Reactive Protein is used to assess cardiovascular risk, so an erroneous low result could lead to an inaccurate cardiovascular risk assessment and delay necessary follow-up examinations.
The affected product was distributed nationwide to 13 states: Alabama, Arizona, California, Connecticut, Florida, Georgia, Kansas, Massachusetts, Missouri, New Jersey, New York, Pennsylvania, and Washington. A total of 3,204 units were recalled. The source does not specify what action affected consumers should take.
Written by software from the official notice below. Not reviewed by a lawyer.
Tina-quant Cardiac C-reactive Protein (Latex) High Sensitive (CRPHS) lot number 604450 (catalog number 11972855216) shows an under-recovery of up to -25% at concentrations below 5 mg/L on the MODULAR ANALYTICS P module. this issue can lead to erroneous low CRPHS results. CRPHS is used as a marker for the prediction of cardiovascular risk. An erroneous low result could lead to an incorrect cardiovascular risk assessment and subsequent delay of further examination.
Reason for recall: Tina-quant Cardiac C-reactive Protein (Latex) High Sensitive (CRPHS) lot number 604450 (catalog number 11972855216) shows an under-recovery of up to -25% at concentrations below 5 mg/L on the MODULAR ANALYTICS P module. this issue can lead to erroneous low CRPHS results. CRPHS is used as a marker for the prediction of cardiovascular risk. An erroneous low result could lead to an incorrect cardiovascular risk assessment and subsequent delay of further examination. Distribution: Nationwide Distribution including AL, AZ, CA, CT, FL, GA, KS, MA, MO, NJ, NY, PA, and WA. Quantity: 3204 Lot/code info: Catalog number: 11972855216, lot number 60445001
Official record: FDA (Device enforcement) ↗
Republished from the official source above; details can change — the source record controls.